Literature DB >> 27587035

A phantom design for assessment of detectability in PET imaging.

Scott D Wollenweber1, Adam M Alessio2, Paul E Kinahan2.   

Abstract

PURPOSE: The primary clinical role of positron emission tomography (PET) imaging is the detection of anomalous regions of (18)F-FDG uptake, which are often indicative of malignant lesions. The goal of this work was to create a task-configurable fillable phantom for realistic measurements of detectability in PET imaging. Design goals included simplicity, adjustable feature size, realistic size and contrast levels, and inclusion of a lumpy (i.e., heterogeneous) background.
METHODS: The detection targets were hollow 3D-printed dodecahedral nylon features. The exostructure sphere-like features created voids in a background of small, solid non-porous plastic (acrylic) spheres inside a fillable tank. The features filled at full concentration while the background concentration was reduced due to filling only between the solid spheres.
RESULTS: Multiple iterations of feature size and phantom construction were used to determine a configuration at the limit of detectability for a PET/CT system. A full-scale design used a 20 cm uniform cylinder (head-size) filled with a fixed pattern of features at a contrast of approximately 3:1. Known signal-present and signal-absent PET sub-images were extracted from multiple scans of the same phantom and with detectability in a challenging (i.e., useful) range. These images enabled calculation and comparison of the quantitative observer detectability metrics between scanner designs and image reconstruction methods. The phantom design has several advantages including filling simplicity, wall-less contrast features, the control of the detectability range via feature size, and a clinically realistic lumpy background.
CONCLUSIONS: This phantom provides a practical method for testing and comparison of lesion detectability as a function of imaging system, acquisition parameters, and image reconstruction methods and parameters.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27587035     DOI: 10.1118/1.4960365

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  6 in total

Review 1.  Transpathology: molecular imaging-based pathology.

Authors:  Mei Tian; Xuexin He; Chentao Jin; Xiao He; Shuang Wu; Rui Zhou; Xiaohui Zhang; Kai Zhang; Weizhong Gu; Jing Wang; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-13       Impact factor: 9.236

Review 2.  Physical imaging phantoms for simulation of tumor heterogeneity in PET, CT, and MRI: An overview of existing designs.

Authors:  Alejandra Valladares; Thomas Beyer; Ivo Rausch
Journal:  Med Phys       Date:  2020-02-12       Impact factor: 4.071

3.  A multi-modality physical phantom for mimicking tumor heterogeneity patterns in PET/CT and PET/MRI.

Authors:  Alejandra Valladares; Thomas Beyer; Laszlo Papp; Elisabeth Salomon; Ivo Rausch
Journal:  Med Phys       Date:  2022-07-25       Impact factor: 4.506

Review 4.  Recent advances on the development of phantoms using 3D printing for imaging with CT, MRI, PET, SPECT, and ultrasound.

Authors:  Valeria Filippou; Charalampos Tsoumpas
Journal:  Med Phys       Date:  2018-06-22       Impact factor: 4.071

5.  Advanced quantitative evaluation of PET systems using the ACR phantom and NiftyPET software.

Authors:  Pawel J Markiewicz; Casper da Costa-Luis; J Dickson; A Barnes; G Krokos; J MacKewn; T Clark; C Wimberley; G MacNaught; M M Yaqub; J D Gispert; B F Hutton; P Marsden; A Hammers; A J Reader; S Ourselin; K Herholz; J C Matthews; F Barkhof
Journal:  Med Phys       Date:  2022-03-31       Impact factor: 4.506

6.  Synergistic impact of motion and acquisition/reconstruction parameters on 18 F-FDG PET radiomic features in non-small cell lung cancer: Phantom and clinical studies.

Authors:  Seyyed Ali Hosseini; Isaac Shiri; Ghasem Hajianfar; Bahador Bahadorzadeh; Pardis Ghafarian; Habib Zaidi; Mohammad Reza Ay
Journal:  Med Phys       Date:  2022-04-11       Impact factor: 4.506

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.